Filing Details

Accession Number:
0001161697-21-000410
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-08-26 16:47:03
Reporting Period:
2021-08-25
Accepted Time:
2021-08-26 16:47:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1369568 Catalyst Pharmaceuticals Inc. CPRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1402535 Steve Miller 355 Alhambra Circle, Suite 801
Coral Gables FL 33134
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Per Share Acquisiton 2021-08-25 120,000 $3.12 821,724 No 4 M Direct
Common Stock, Par Value $0.001 Per Share Disposition 2021-08-25 80,000 $5.56 741,724 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Options to purchase common stock Disposition 2021-08-25 120,000 $0.00 120,000 $3.12
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,405,000 2021-08-28 No 4 A Direct
Footnotes
  1. Shares were sold to cover exercise price of options and tax withholding requirements.
  2. Shares were sold in various lots from $5.51 to $5.61 per share. The listed sale price represents a weighted average price for the shares sold.
  3. Options vested in three annual tranches beginning on August 28, 2015.